West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
246.95
+1.50 (0.61%)
Aug 29, 2025, 4:00 PM - Market closed
WST Revenue
West Pharmaceutical Services had revenue of $766.50M in the quarter ending June 30, 2025, with 9.17% growth. This brings the company's revenue in the last twelve months to $2.96B, up 2.90% year-over-year. In the year 2024, West Pharmaceutical Services had annual revenue of $2.89B, down -1.92%.
Revenue (ttm)
$2.96B
Revenue Growth
+2.90%
P/S Ratio
6.05
Revenue / Employee
$279,264
Employees
10,600
Market Cap
17.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
WST News
- 5 days ago - Best Dividend Aristocrats For September 2025 - Seeking Alpha
- 11 days ago - West to Participate in Upcoming Investor Conferences in September 2025 - PRNewsWire
- 26 days ago - Top 50 High-Quality Dividend Stocks For August 2025 - Seeking Alpha
- 4 weeks ago - West Pharmaceutical: Q2 Earnings Suggest Recovery - Seeking Alpha
- 5 weeks ago - West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking Problem - Seeking Alpha
- 5 weeks ago - West Pharmaceutical Services, Inc. (WST) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars - Benzinga
- 5 weeks ago - West Pharma raises annual profit forecast on strong demand for its drug components - Reuters